BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 24054020)

  • 1. [Comparison of two gastric cancer screening schemes in a high-risk population].
    Lü YL; Li Y; Liu GS; Wu Q; Liu WD; Li SJ; Cao CQ; Wu XZ; Liu DM; Zhang L; Zhang LF; Ma JL; Pan KF; Zhang L; You WC
    Zhonghua Zhong Liu Za Zhi; 2013 May; 35(5):394-7. PubMed ID: 24054020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Population-based gastric cancer screening in Zhuanghe, Liaoning, from 1997 to 2011].
    Yuan Y
    Zhonghua Zhong Liu Za Zhi; 2012 Jul; 34(7):538-42. PubMed ID: 22967474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum pepsinogen test for early detection of gastric cancer in a European country.
    Lomba-Viana R; Dinis-Ribeiro M; Fonseca F; Vieira AS; Bento MJ; Lomba-Viana H
    Eur J Gastroenterol Hepatol; 2012 Jan; 24(1):37-41. PubMed ID: 21989121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of the efficacy of gastric cancer screening in rural population in Henan Province].
    Zhang M; Li X; Zhang S; Chen Q; Liu S; Guo L; Lu J; Sun X
    Zhonghua Zhong Liu Za Zhi; 2016 Jan; 38(1):73-7. PubMed ID: 26796811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term results of gastric cancer screening using the serum pepsinogen test method among an asymptomatic middle-aged Japanese population.
    Miki K; Fujishiro M; Kodashima S; Yahagi N
    Dig Endosc; 2009 Apr; 21(2):78-81. PubMed ID: 19691778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Studies on the cut-off value of serum pepsinogen abnormality for screening chronic atrophic gastritis and gastric carcinoma].
    Li YH; Zhang XH; Huang B; Wang JL; Mi JM; Shen HT; Zhang ZG; Yan X; Xing LX; Wang SJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Oct; 27(10):840-4. PubMed ID: 17343174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastric intraepithelial neoplasia in a Western population.
    Raftopoulos SC; Kumarasinghe P; de Boer B; Iacobelli J; Kontorinis N; Fermoyle S; Olynyk J; Forrest C; Ee HC; Yusoff IF
    Eur J Gastroenterol Hepatol; 2012 Jan; 24(1):48-54. PubMed ID: 22081007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of gastric cancer screening by endoscopy testing through the National Cancer Screening Program of Korea.
    Choi KS; Jun JK; Lee HY; Park S; Jung KW; Han MA; Choi IJ; Park EC
    Cancer Sci; 2011 Aug; 102(8):1559-64. PubMed ID: 21564421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnifying endoscopy with narrow-band imaging may improve diagnostic accuracy of differentiated gastric intraepithelial neoplasia: a feasibility study.
    Wang SF; Yang YS; Yuan J; Lu ZS; Zhang XL; Sun G; Peng LH; Ling-hu EQ; Meng JY
    Chin Med J (Engl); 2012 Mar; 125(5):728-32. PubMed ID: 22490564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of results of endoscopic screening of esophageal, gastric cardia and gastric cancers in high risk population].
    Zhang J; Wang F; Zhang Y; Quan P; Liu S; Sun X; Lu J
    Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):158-60. PubMed ID: 24796469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlation of serum pepsinogen level and gastric mucosal changes of residents in the high incidence area of gastric cancer].
    Zhang XH; Huang B; Wang JL; Li YH; Mi JM; Shen HT; Zhang ZG; Yan X; Xing LX; Wang SJ
    Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):507-11. PubMed ID: 17147114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validity of serum pepsinogen levels and quininium resin test combined for gastric cancer screening.
    Kim JR; Lee K; Jung WT; Lee OJ; Kim TH; Kim HJ; Lee JS; Passaro DJ
    Cancer Detect Prev; 2005; 29(6):570-5. PubMed ID: 16289505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a high risk gastric cancer group using serum pepsinogen after successful eradication of Helicobacter pylori.
    Haneda M; Kato M; Ishigaki S; Suzuki M; Takahashi M; Nakagawa M; Ono S; Mori Y; Mabe K; Nakagawa S; Kudo T; Shimizu Y; Asaka M
    J Gastroenterol Hepatol; 2013 Jan; 28(1):78-83. PubMed ID: 23034090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased death from gastric cancer by endoscopic screening: association with a population-based cancer registry.
    Hosokawa O; Miyanaga T; Kaizaki Y; Hattori M; Dohden K; Ohta K; Itou Y; Aoyagi H
    Scand J Gastroenterol; 2008; 43(9):1112-5. PubMed ID: 18609154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of serum pepsinogen I , II and osteopontin co-detection in gastric cancer screening].
    Gong YH; Sun LP; Yuan Y
    Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):691-3. PubMed ID: 17274377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum pepsinogen I, pepsinogen II, and gastrin 17 in relatives of gastric cancer patients: comparative study with type and severity of gastritis.
    Haj-Sheykholeslami A; Rakhshani N; Amirzargar A; Rafiee R; Shahidi SM; Nikbin B; Khosravi F; Massarrat S
    Clin Gastroenterol Hepatol; 2008 Feb; 6(2):174-9. PubMed ID: 18237867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Western long-term accuracy of serum pepsinogen-based gastric cancer screening.
    Castro C; Dinis-Ribeiro M; Rodrigues ANG; Calheiros T; Santos J; Pereira P; Ramos M; Cunha H; Andrade M; Costa A; Sá L; Antunes L; Bento MJ; Lomba-Viana R
    Eur J Gastroenterol Hepatol; 2018 Mar; 30(3):274-277. PubMed ID: 29215432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of methylene blue-directed biopsies and four-quadrant biopsies in the detection of high-grade intraepithelial neoplasia and early cancer in Barrett's oesophagus.
    Gossner L; Pech O; May A; Vieth M; Stolte M; Ell C
    Dig Liver Dis; 2006 Oct; 38(10):724-9. PubMed ID: 16911879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum pepsinogen I and II levels in various gastric disorders with special reference to their use as a screening test for carcinoma stomach.
    Parthasarathy G; Maroju NK; Kate V; Ananthakrishnan N; Sridhar MG
    Trop Gastroenterol; 2007; 28(4):166-70. PubMed ID: 18416347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer high-risk subjects identified by serum pepsinogen tests: outcomes after 10-year follow-up in asymptomatic middle-aged males.
    Yanaoka K; Oka M; Mukoubayashi C; Yoshimura N; Enomoto S; Iguchi M; Magari H; Utsunomiya H; Tamai H; Arii K; Ohata H; Fujishiro M; Takeshita T; Mohara O; Ichinose M
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):838-45. PubMed ID: 18398025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.